Answers are grounded in this paper and cite their sources.
Genetic variants that mimic the effect of ATP citrate lyase inhibitors and statins appeared to lower plasma LDL cholesterol levels by the same mechanism of action and were associated with similar effects on the risk of cardiovascular disease per unit decrease in the LDL cholesterol level. (Funded by Esperion Therapeutics and others.).
No takes yet. Share an insight, caveat, or question.
Ference et al. (2019) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: